UPS Healthcare is investing more than 20 million EUR in over 200 state-of-the-art, temperature-controlled vehicles.
“Whether it’s small parcels or large pallets, our pan-European end-to-end cold chain ground network is equipped to manage the most complex healthcare products. From transporting active ingredients or last-mile deliveries to hospitals, laboratories, pharmacies, and patients, we provide control, adaptability, and real-time monitoring to simplify the most time and temperature-sensitive supply chains.” said Felipe Morgulis, President of UPS Healthcare, Europe and LATAM.
These new vehicles, set to upgrade and expand the current fleet, will add to UPS’s fleet of more than 1,100 cold chain vehicles – already the largest in the world. Supporting long-haul and last-mile deliveries, the vehicles will help meet the growing needs of Europe’s healthcare industry across the entire region, with the cold-chain market projected to reach $23.7 billion by 2030.
The dual-temperature vehicles provide transportation between 2 to 8 degrees and 15 to 25 degrees Celsius, ensuring reliable and secure deliveries to wholesalers, hospitals, and pharmacies. This GDP-compliant service includes comprehensive vendor management and digital quality management systems ensuring all customers’ quality requirements are met.
UPS Healthcare’s global network of healthcare-compliant distribution space topped 1.7 million square metres in 2023, more than doubling warehouse space compared to 2020. Through acquisitions of Bomi Group, MNX, and Chabas Sante, UPS Healthcare has expanded its end-to-end cold chain capabilities, enabling customers to reach new markets more flexibly.
